Adagio Medical Holdings: Director Departs, New Director Appointed
Ticker: ADGM · Form: 8-K · Filed: Apr 23, 2025 · CIK: 2006986
| Field | Detail |
|---|---|
| Company | Adagio Medical Holdings, INC. (ADGM) |
| Form Type | 8-K |
| Filed Date | Apr 23, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: board-changes, officer-appointments, compensatory-arrangements
TL;DR
Adagio Medical Holdings board shake-up: Dr. Smith out, Dr. McGinley in.
AI Summary
Adagio Medical Holdings, Inc. announced on April 17, 2025, the departure of director Dr. David L. D. Smith and the appointment of Dr. Michael J. McGinley as a new director. The company also reported on compensatory arrangements for its officers.
Why It Matters
Changes in board composition can signal shifts in company strategy or governance, potentially impacting investor confidence and future performance.
Risk Assessment
Risk Level: low — The filing primarily concerns routine board and officer changes, with no immediate financial distress or significant operational shifts indicated.
Key Players & Entities
- Adagio Medical Holdings, Inc. (company) — Registrant
- Dr. David L. D. Smith (person) — Departing Director
- Dr. Michael J. McGinley (person) — Appointed Director
- 001-42199 (company) — SEC File Number
- 26051 Merit Circle, Suite 102, Laguna Hills, CA 92653 (company) — Business Address
FAQ
Who is the departing director and when did their departure become effective?
Dr. David L. D. Smith is the departing director, with the earliest event reported as April 17, 2025.
Who is the newly appointed director?
Dr. Michael J. McGinley has been appointed as a director.
What is the exact date of the earliest event reported in this 8-K filing?
The date of the earliest event reported is April 17, 2025.
What is Adagio Medical Holdings, Inc.'s state of incorporation and fiscal year end?
Adagio Medical Holdings, Inc. is incorporated in Delaware and its fiscal year ends on December 31.
What are the main items covered in this 8-K filing?
This filing covers the departure of directors or certain officers, election of directors, appointment of certain officers, compensatory arrangements of certain officers, and financial statements and exhibits.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on April 23, 2025 by Dr. David L. D. Smith regarding Adagio Medical Holdings, Inc. (ADGM).